Olive Union Max vs Otofonix Encore

The Olive Union Max is a behind-the-ear OTC hearing aid priced at $190, earning a B grade with a SoundScore of 3.4/5 in HearAdvisor's lab testing. This budget-friendly device ranks #41 of 65 OTC hearing aids tested. In our lab testing, the Max shows a distinctive performance profile with clear strengths and limitations. Music streaming stands out with a strong 4.0/5 score, measuring 2.08 points above the OTC category average—making it one of the better choices for audio entertainment. Feedback handling is excellent at 5.0/5, meaning the device maintains stability without whistling during typical daily activities. However, speech performance presents challenges. Speech in quiet scores a mixed 2.6/5, falling 0.21 points below the category average, while speech in noise is low at 1.0/5, measuring 0.48 points below average. Own-voice comfort also scores low at 1.6/5, sitting 0.91 points below the category average—users may notice their own voice sounds unnatural or hollow. The Olive Union Max is best suited for budget-conscious consumers who prioritize music and media streaming over demanding listening environments. Those who frequently need to follow conversations in noisy settings like restaurants or social gatherings may find the speech-in-noise limitations frustrating. For basic amplification in quieter environments with excellent streaming quality at an accessible price point, the Max offers reasonable value despite its speech performance trade-offs.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.